Professor Paulo E. Stanga
To book a consultation with Professor Paulo E. Stanga:
Call: 01625 581781
Professor Paulo E. Stanga
Manchester Royal Eye Hospital
Consultant Ophthalmologist and Vitreoretinal Surgeon
Professor of Ophthalmology and Retinal Regeneration
Current NHS hospital/university posts
Consultant Ophthalmologist and Vitreoretinal Surgeon for the Manchester Royal Eye Hospital and Professor of Ophthalmology and Retinal Regeneration for the University of Manchester.
Prof. Stanga is Director of the Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester CRF and its Retinal Clinical-Research Fellowship Program, MREH Lead for the Retinal Laser Service, MREH and University of Manchester Laser Safety Representative. Professor Paulo Stanga whilst also running the Manchester Vision Regeneration Lab, is the PI in various Industry-sponsored research projects.
Cataract and Lens extraction surgery (phacoemulsification and intraocular lens implantation)
Laser Capsulotomy (YAG LASER)
Pars plana vitrectomy
Retinal detachment surgery
Macular hole surgery, without prolonged positioning
Intravitreal ocriplasmin (Jetrea) injection for VMA and small macular holes
Removal of epiretinal membranes (macular pucker)
Vitrectomy for diabetic eye disease
Intravitreal injections for diabetic macular oedema (anti-VEGF- Avastin, Lucentis, Eylea. Steroid – Triamcinolone, Triesence, Ozurdex.)
Removal of vitreous floaters
Intravitreal injections for wet age-related macular degeneration (anti-VEGF; Avastin, Lucentis, Eylea)
Management of complications of cataract surgery
Laser treatment for retinal tears
Laser treatment of diabetic retinopathy (PASCAL laser)
Treatment of retinal vein occlusion by laser and /or intravitreal injection
Ozurdex implants for retinal vein occlusion
Argus II Electronic Retinal Implant for artificial Vision or Bionic Eye.
Director of the Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester CRF and its Clinical, Surgical and Research Fellowship Program. The MVR Lab team focuses on developing research and therapies using the most advanced diagnostic and treatment devices.
Prof. Stanga is also, former President of the Ophthalmic Imaging Association and Member of the Scientific Committee of the Royal College of Ophthalmologists amongst others, and former Chair of the MREH Research Steering Committee.
Professor Stanga also leads the Retinal Laser Committee and is the Laser Safety Officer for the Manchester Royal Eye Hospital.
I have worked in Ophthalmology for over 26 years and I am currently a Consultant Ophthalmologist and Vitreoretinal Surgeon for the Manchester Royal Eye Hospital. I am also Professor of Ophthalmology and Retinal Regeneration for the University of Manchester.
I specialize in vitreo-retinal disorders that require either medical or surgical treatment, such as age-related macular degeneration (AMD), diabetic retinopathy and maculopathy, retinal vein occlusions, macular hole, retinal detachment, pediatric retinal diseases, genetic or inherited/ diseases, ocular trauma and cataract surgery and the management of its complications.
My current research interests are in the vitreo-retinal imaging, pharmacological, surgical and laser treatment of proliferative diabetic retinopathy and macular oedema, laser-tissue interaction, choroidal neovascularization secondary to age-related macular degeneration and myopia, hypersonic vitrectomy surgery, gene therapy and electronic retinal implants for artificial vision or "bionic eye"
I have significantly contributed towards the field of Retinal Imaging, retinal laser techniques and the development of new technologies for vitrectomy surgery such as hypersonic vitrectomy.
Since 1993 I have worked in the development and application of new outpatient and surgical therapies and technologies such as retrobulbar Interferon alpha-2a, genetics of AMD, retinal pigment epithelium translocation surgery, macular translocation surgery, micropulse diode and Pascal® laser photocoagulation, optical coherence tomography (OCT), wide-angle fundus fluorescein angiography and fundus autofluorescence technology (Optos), antiangiogenic intravitreal drugs and hypersonic vitrectomy surgical systems.
I introduced, amongst others, Optical Coherence Tomography (OCT) into the clinical setting in the UK (1998), Pascal® Laser system and retinal treatment strategies into the EU (2006) and based on personally led imaging and clinical research on it and I have also pioneered Swept-Source OCT, having introduced it into the EU (2012) and Optos Wide-Field imaging and Optos-guided tissue-sparing laser treatment strategies.
My research on Artificial Vision has been highlighted as a significant achievement by the University of Manchester and the NHS Central Manchester Foundation Trust and listed as an important research landmark in the rich research heritage of the city of Manchester by the Manchester European City of Science 2016 Committee. My research is also one of only two highlighted on the current national NIHR brochure.
I have set-up and I am the Principal Investigator (PI) for a Manchester-only Pilot Study of the Argus II electronic retinal Implant or Bionic Eye system in Age-Related Macular Degeneration (AMD) since 2009. I have also already successfully carried out the first ever implantation of an electronic retinal implant in AMD, which has resulted in the first ever 5 human beings with integrated artificial (central) and natural (peripheral) vision.
I am MREH Principal Investigator for a gene therapy trial in Choroideremia.
In 1998, I introduced Optical Coherence Tomography (OCT) imaging into the clinical setting in the UK. This technology has proved to be a game changer in the diagnosis and treatment of retinal diseases such as macular degeneration, macular hole, diabetic retinopathy and all maculopathies. It is now an indispensable and everyday use examination tool in Ophthalmology.
In 2006, I also introduced into the EU the new retinal laser photocoagulation system Pattern Scan Laser (Pascal) and since then I have been developing new retinal laser photocoagulation techniques/strategies for the treatment of Diabetic Retinopathy such as, sub-threshold or imaging guided laser.
As a result of the research that I lead, the Manchester Royal Eye Hospital and the University of Manchester are now one of the world leaders in these fields.
I have chaired several international meetings, amongst others and in Manchester: The British and Eire Vitreoretinal Association (BEAVRS) Annual Meeting in 2004 and the Tubingen Retinal Detachment Course and Manchester Retina Course in 2009. In 2014, I chaired the Imaging Day during the MREH Bicentenary celebrations as well as the Retina Day and the Retinal Imaging Symposium and during the Annual Meeting of the Royal College of Ophthalmologists.
As a marker of my International standing, it can be mentioned that by invitation of the Royal College of Ophthalmologists, I have also chaired its annual meeting as a yearly speaker since 2012. I have also chaired the Retinal Imaging day symposium during its annual meeting and the Retina day meeting since 2007.
I am involved in the Undergraduate/Postgraduate Teaching of Medical, PhD and Optometry Students, Nurses, Orthoptists, Ophthalmology and Vision Sciences MSc. I am Accredited Trust Educational Supervisor providing clinical and surgical training for F2, SpR and VR Fellow at any given time and lectures to the GP and Optometric community.
I am a frequently Invited Speaker at national and international meetings representing the MREH, MVR Lab/NIHR Wellcome Trust Manchester CRF and the University of Manchester.
I have also set up and run a Retina Research Fellowship Program.
Some of my accolades include: Award for Outstanding Contribution to Ophthalmology in Singapore (Singapore, 2006), Award in Appreciation for Support and Far Reaching Contributions at the NGH Eye Institute (Singapore, 2008), American Academy of Ophthalmology Achievement Award (USA, 2011), Outstanding Personality in Science by the City Council (Legislatura Portena) of the city of Buenos Aires (Argentina, 2012), Award for Outstanding Contribution to Retinology in Poland (Krakow, 2014)
Cataract surgery with Intraocular Lens implantation
Age-related macular degeneration (AMD)
Diabetic Maculopathy and Retinopathy
Laser photocoagulation of diabetic retinopathy and maculopathy
Vitreoretinal surgery for retinal detachment
Secretary: Anne Molloy
Tel: 01625 581781
Fax: 01625 581 789